Safety of curcumin for anal precancer
Part of Cancer clinical trials.
This study tests whether a curcumin (turmeric) suppository can safely treat anal precancerous changes called AIN 2 or AIN 3. It may be an option if you have high-grade cell changes and want to avoid more invasive treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years old or older.
- You have a biopsy-confirmed anal precancer (AIN 2 or AIN 3) that hasn't been treated yet, or a Pap-like test showing high-grade cell changes (ASC-H or HSIL).
- You are willing to fill out a daily study diary.
- You do not have a serious chronic illness that is getting worse (like heart disease, severe lung disease, or uncontrolled diabetes).
- You have never had anal cancer, and you are not pregnant or planning to become pregnant in the next 3 months.
- You are not currently using or have not used intravenous drugs (except for medical reasons) or had alcohol abuse in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an artesunate ointment to treat high-grade anal precancer (HSIL) in people who do not have HIV. The goal is to see if the ointment can clear the abnormal cells caused by HPV.
This Phase 2 study tests whether a curcumin (a natural plant compound) cream/gel applied to the cervix can help treat cervical cell changes linked to HPV. It focuses on people with mild (LSIL) or recently treated severe (HSIL) precancer changes, aiming to reduce disease and improve healing.
This study tests if a probiotic called EXE-346 can help clear anal high-grade squamous intraepithelial lesions (HSIL), a precancerous condition, in people with HIV who are on effective antiretroviral therapy. If you have anal HSIL that wasn't fully removed by biopsy, you may be able to join.
This study tests whether curcumin (a supplement made from turmeric) can prevent low-risk prostate cancer from progressing while you stay on active surveillance. If you qualify, you would take curcumin and be monitored closely with regular checkups.
This trial tests whether a curcumin (turmeric) supplement can help women with advanced cervical cancer who are about to start standard treatment with chemotherapy and radiation. It aims to see if adding curcumin improves outcomes.
This trial tests if a highly absorbable form of curcumin (a natural compound from turmeric) added to standard chemoradiation before surgery can improve outcomes for people with mid-to-low rectal cancer. The study will also look at tumor tissue to understand how the treatment works.
Hear when a new Anal High Grade Squamous Intraepithelial Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.